Pacer Advisors Inc. reduced its position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 7.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 12,773 shares of the company’s stock after selling 1,091 shares during the period. Pacer Advisors Inc.’s holdings in Henry Schein were worth $884,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Cromwell Holdings LLC raised its stake in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the period. Versant Capital Management Inc raised its position in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares during the period. City State Bank acquired a new position in Henry Schein in the fourth quarter valued at $55,000. Farther Finance Advisors LLC boosted its holdings in Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its position in Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the company. Jefferies Financial Group lifted their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Evercore ISI raised their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Barrington Research upped their price target on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.10.
Insider Buying and Selling
In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.14% of the stock is owned by company insiders.
Henry Schein Stock Performance
Shares of HSIC stock opened at $79.57 on Tuesday. The stock has a market capitalization of $9.92 billion, a price-to-earnings ratio of 32.74, a PEG ratio of 2.21 and a beta of 0.91. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The company’s 50-day simple moving average is $73.47 and its 200-day simple moving average is $71.52. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the company posted $1.32 earnings per share. The firm’s revenue was up .4% on a year-over-year basis. Equities analysts anticipate that Henry Schein, Inc. will post 4.76 earnings per share for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
- Five stocks we like better than Henry Schein
- What Is WallStreetBets and What Stocks Are They Targeting?
- How to Invest in Small Cap Stocks
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- These Are the Dividend Stocks Insiders Bought in January
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.